Human adenovirus multi-serotype Hexon chimeric antigen as well as preparation method and application thereof

By selecting Hexon protein-specific epitope regions of the main subtype of human adenovirus, multi-serose Hexon chimeric antigens are prepared in tandem, the difficulty of preparing diagnostic kits caused by the single antigen raw materials in the prior art is solved, and the risk of missed detection is achieved. Efficient and sensitive multi-subtype adenovirus detection.

CN119060205APending Publication Date: 2024-12-03QINGDAO HIGHTOP BIOTECH
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202411379872.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-30
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

Most of the existing human adenovirus diagnostic antigen materials are single subtypes, which makes it difficult to prepare diagnostic kits and risk of missed detection, so it is impossible to effectively detect multiple subtypes of adenoviruses.

Method used

By selecting conserved and hypervariable region-specific epitope regions of human adenovirus Hexon proteins of type 3, type 7, and type 55, multi-serose Hexon chimeric antigens were prepared in tandem and applied to colloidal gold detection kits. As a diagnostic antigen.

Benefits of technology

It improves antigenicity and positive detection rate, simplifies the preparation process of the kit, enhances the detection ability of various subtypes of adenoviruses, and reduces the risk of missed detection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119060205A_ABST
    Figure CN119060205A_ABST
Patent Text Reader

Abstract

The invention relates to a human adenovirus multi-serotype Hexon chimeric antigen, which is formed by connecting dominant epitope regions of conserved regions of Hexon proteins of type 3, type 7 and type 55 and specific dominant epitope regions of hypervariable regions in series, and dominant epitopes of the Hexon proteins of type 3 comprise 39-81aa and 103-258aa fragments; the dominant epitope of the type 7 Hexon protein comprises a fragment 153 to 255aa; the dominant epitope of the type 55 Hexon protein comprises a 175-319aa fragment. The invention also relates to a preparation method and application of the antigen. According to the invention, Hexon advantage and specific antigen fragments of several main subtypes infected by domestic human adenovirus are selected, dominant epitope regions of conserved regions of various subtypes are combined, the human adenovirus antigen with strong antigenicity and high positive detection rate is prepared by chimeric expression of the Hexon advantage and specific antigen fragments, and the human adenovirus antigen is used as a diagnosis antigen of a human adenovirus antibody to be applied to a detection kit.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of gene recombination and immune diagnosis, and in particular to a human adenovirus multi-serotype Hexon chimeric antigen. Background Art

[0002] Adenovirus is a double-stranded DNA virus without an outer shell. It belongs to the Adenoviridae family. The genome is about 34.7kb long. The capsid is a regular icosahedral structure with a diameter of 80-110nm. The core is composed of double-stranded DNA and protein, with a nucleocapsid on the outside, and 252 capsomers on it, which are composed of 240 hexons and 12 pentons. Each hexon is a homotrimer of hexon protein. The hexon molecule of the trimer has a triangular spire and a pentahedral base. The tower area is composed of 4 rings, namely Loop1-Loop4 (L1-L4); the base contains two regions P1-P2; there is no lipid envelope on the outside. There are more than 80 known adenovirus types, which are divided into 7 serogroups from A to G. Each serogroup contains multiple types, most of which are pathogenic to humans. Human adenovirus (HAdV) infection is one of the important pathogens of acute respiratory infections. Adenovirus infection can occur throughout the year, with a high incidence in summer and winter. Children and adults with poor immunity are susceptible. The respiratory adenoviruses prevalent in my country are mainly types 1-7, 11, 14 and 55, of which type 7 and type 3 are the main ones, accounting for 62.33% and 24.97% of the outbreak cases, respectively. In recent years, it has been found that adenovirus type 55 infection is the most common in southwest my country. In recent years, there have been continuous reports of sporadic severe pneumonia in adults caused by adenovirus type 55, suggesting that adenovirus type 55 infection has become one of the important causes of community-acquired pneumonia in adults and needs to be closely monitored. Studies on adenovirus antigenic epitopes have found that there are three main structural proteins on the surface of adenovirus particles: hexon protein, spike protein and penton protein, which can produce antibodies against adenovirus. Among them, hexon is the largest and most abundant protein in the adenovirus capsid, accounting for more than 83% of the capsid protein. It has strong antigenicity and exposure, and is the main source of inter-type specific epitopes. Hexon amino acids have 7 hypervariable regions (HVR1, aa136-157; HVR2, aa181-191; HVR3, aa206-218; HVR4, aa249-260; HVR5, aa271-281; ​​HVR6, aa303-312; HVR7, aa420-457), of which HVR1 to HVR6 are located on macroloop L1, and HVR7 is located on macroloop L2. These highly variable regions cover more than 90% of the surface of the virus. These hypervariable regions located on the outer surface are also rich in antigenic epitopes and are important markers for distinguishing different serotypes of adenovirus. Therefore, the epitopes on hexon are type-specific, an important target for the diagnosis of viral infectious diseases, and a standard for diagnosing different serotypes.

[0003] Since there are many subtypes of infective human adenoviruses and Hexon antibodies are type-specific, some antigen raw materials used for human adenovirus diagnosis on the market are of a single subtype and can only detect one subtype of adenovirus, while others require multiple subtype raw materials to be mixed in different proportions before use, which increases the difficulty in the preparation of diagnostic kits and still poses a risk of missed detection. Therefore, there is a need for an antigen raw material that can target multiple subtypes. Summary of the invention

[0004] The technical problem to be solved by the present invention is to overcome the defects of the existing human adenovirus diagnosis antigen raw material subtype being single and the difficulty in preparing a diagnostic kit from mixed raw materials, and to provide a human adenovirus multi-serotype Hexon chimeric antigen and its preparation method and application. The Hexon dominant and specific antigen fragments of several major subtypes of domestically infected human adenovirus are selected, combined with the dominant epitope regions of the conserved regions of multiple subtypes, and the chimeric expression is prepared to obtain a human adenovirus antigen with strong antigenicity and a high positive detection rate, and the antigen is used as a diagnostic antigen for human adenovirus antibodies in a detection kit.

[0005] The present invention relates to adenovirus multi-serotype Hexon chimeric antigen, wherein the antigen is composed of a dominant epitope region of the conservative region of type 3, type 7, and type 55 Hexon proteins and a specific dominant epitope region of the hypervariable region in series. The dominant epitope of type 3 Hexon protein includes 39-81aa and 103-258aa fragments, and their amino acid sequences are as described in SEQ ID NO.3 and SEQ ID NO.4, respectively; the dominant epitope of type 7 Hexon protein includes 153-255aa fragment, and its amino acid sequence is as described in SEQ ID NO.5, respectively; the dominant epitope of type 55 Hexon protein includes 175-319aa fragment, and its amino acid sequence is as described in SEQ ID NO.5, respectively.

[0006] Furthermore, the dominant epitope regions of the type 3, type 7, and type 55 Hexon proteins are connected by connecting peptides GGGS, (GGGS) 2, and AEAAAKA.

[0007] Furthermore, the sequence of the amino acid sequence fragment of the antigen is as described in SEQ ID NO.1.

[0008] Method for preparing human adenovirus multi-serotype Hexon chimeric antigen The human adenovirus multi-serotype Hexon chimeric antigen is the human adenovirus multi-serotype Hexon chimeric antigen mentioned above, and the preparation method comprises the following steps: S1-Through the analysis of the dominant epitopes in the conservative region and the specific dominant epitopes in the hypervariable region of the hexon protein of human adenovirus type 3, type 7, and type 55, the 39-81aa and 103-258aa fragments of type 3 Hexon protein, the 153-255aa fragment of type 7 Hexon protein, and the 175-319aa fragment sequence of type 55 Hexon protein were selected, and the nucleotide sequence that translates the amino acid was obtained as the target gene through codon optimization. The target gene was connected to the prokaryotic expression vector pGEX-4T-1 through gene synthesis, and the recombinant vector pGEX-4T-1-H3755 was successfully obtained; S2-transform the recombinant expression vector pGEX-4T-1-H3755 obtained in step S1 into the host bacteria, and screen to obtain the recombinant engineered bacteria B / pGEX-4T-1-H3755; S3-The recombinant engineered bacteria B / pGEX-4T-1-H3755 obtained in step S2 is cultured and induced to express, and the product is separated and purified to obtain the recombinant human adenovirus multi-serotype Hexon chimeric antigen.

[0009] Furthermore, the base sequence of the target gene obtained by codon optimization in step S1 is as described in SEQ ID NO.2.

[0010] Furthermore, the host strain of the recombinant engineering bacteria B / pGEX-4T-1-H3755 in step S2 is Escherichia coli BL21 (DE3).

[0011] The human adenovirus multi-serotype Hexon chimeric antigen is applied to a colloidal gold kit for detecting human adenovirus antibodies. The human adenovirus multi-serotype Hexon chimeric antigen is the human adenovirus multi-serotype Hexon chimeric antigen mentioned above, and the human adenovirus multi-serotype Hexon chimeric antigen prepared by the above-mentioned human adenovirus multi-serotype Hexon chimeric antigen diagnostic antigen preparation method; the human adenovirus multi-serotype Hexon chimeric antigen is used as the diagnostic antigen of the colloidal gold kit for detecting human adenovirus antibodies.

[0012] Furthermore, the preparation method of the colloidal gold test kit for detecting human adenovirus antibodies comprises the following steps: S21—Colloidal gold labeling: Take 1mL of colloidal gold and put it in a small glass cup, stir and add an appropriate amount of 0.2MK2CO3 to adjust the pH to 7.6, stir for 1min; add 20μg of the human adenovirus multi-serotype Hexon chimeric antigen, stir for 1 min; add 100μL 1% PEG20000, stir for 1min; centrifuge at 5000g for 10 minutes, discard the supernatant, and resuspend the precipitate with 100ul colloidal gold diluent; mix thoroughly and store at 4℃. Dilute the above gold-labeled complex 10 times with colloidal gold diluent and evenly apply it on the glass fiber, dry at 37℃ to make a gold-labeled pad; S22—Nitrocellulose membrane coating: Coating diluent formula: 0.01M PB, pH 7.4, mass percentage concentration of 0.05% trehalose, the test line and quality control line are coated on the NC membrane from bottom to top, and then baked at 37℃ for 30min; S23—Assembly: Assemble the solid-phased NC membrane with the sample pad, S pad, gold label pad, PVC base plate, absorbent paper, and Mark sticker, and cut them into 3-4 mm test strips using a strip cutter.

[0013] Furthermore, the colloidal gold dilution solution component parameters in step S21 are 20 mM PB, 150 mM NaCl, 0.1% PEG20000, 0.1% TritonX-100, 2% Sucrose, and 0.01% NaN3.

[0014] The invention discloses a human adenovirus multi-serotype Hexon chimeric antigen and a preparation method and application thereof, which overcome the defects of the existing human adenovirus diagnosis antigen raw material subtype being single and the difficulty in preparing a diagnostic kit from mixed raw materials, and the like. The invention selects Hexon dominant and specific antigen fragments of several major subtypes of domestically infected human adenoviruses, combines the dominant epitope regions of the conserved regions of multiple subtypes, and prepares the human adenovirus antigen with strong antigenicity and high positive detection rate through chimeric expression, and uses the human adenovirus antigen as a diagnostic antigen for human adenovirus antibodies in a detection kit. BRIEF DESCRIPTION OF THE DRAWINGS

[0015] The following is a further description of a human adenovirus multi-serotype Hexon chimeric antigen and its preparation method and application in conjunction with the accompanying drawings: Figure 1 This is a flowchart of the construction of pGEX-4T-1-H3755 in step 1 of the method for preparing multi-serotype Hexon chimeric antigen of adenovirus; Figure 2 It is the gel image of the expression of the preparation method of multi-serotype Hexon chimeric antigen of adenovirus in step 2; Figure 3This is the SDS-PAGE and SEC-HPLC analysis results after purification in step 3 of the preparation method of my adenovirus multi-serotype Hexon chimeric antigen; Figure 4 This is a comparison chart of the positive quality control of the product in the sensitivity test of the application of the adenovirus multi-serotype Hexon chimeric antigen; Figure 5 This is a comparison chart of the positive quality control of the products in the sensitivity test using the adenovirus multi-serotype Hexon chimeric antigen. DETAILED DESCRIPTION

[0016] In the present invention, unless otherwise clearly specified and limited, the terms "installed", "connected", "connected", "fixed" and the like should be understood in a broad sense, for example, it can be a fixed connection, a detachable connection, or an integral connection; it can be directly connected or indirectly connected through an intermediate medium, it can be the internal connection of two elements or the interaction relationship between two elements. For ordinary technicians in this field, the specific meanings of the above terms in the present invention can be understood according to specific circumstances.

[0017] In the description of the present invention, it should be understood that the terms "left", "right", "front", "back", "top", "bottom", "inside", "outside", etc., indicating directions or positional relationships are based on the directions or positional relationships shown in the accompanying drawings, and are only for the convenience of describing the present invention and simplifying the description, rather than indicating or implying that the device or element referred to must have a specific direction, be constructed and operated in a specific direction, and therefore cannot be understood as a limitation on the present invention.

[0018] The technical solution of the present invention is further described below with specific embodiments, but the protection scope of the present invention is not limited to the following embodiments.

[0019] Embodiment 1: Adenovirus multi-serotype Hexon chimeric antigen The antigen is composed of a series of dominant epitope regions of the conservative regions of type 3, type 7, and type 55 Hexon proteins and specific dominant epitope regions of the hypervariable regions. The dominant epitopes of the type 3 Hexon protein include 39-81aa and 103-258aa fragments, and their amino acid sequences are described in SEQ ID NO.3 and SEQ ID NO.4, respectively; the dominant epitopes of the type 7 Hexon protein include 153-255aa fragments, and their amino acid sequences are described in SEQ ID NO.5, respectively; the dominant epitopes of the type 55 Hexon protein include 175-319aa fragments, and their amino acid sequences are described in SEQ ID NO.5, respectively. The dominant epitope regions of the type 3, type 7, and type 55 Hexon proteins are connected by connecting peptides GGGS, (GGGS)2, and AEAAAKA. The sequence of the amino acid sequence fragment of the antigen is described in SEQ ID NO.1.

[0020] Embodiment 2: Method for preparing human adenovirus multi-serotype Hexon chimeric antigen The human adenovirus multi-serotype Hexon chimeric antigen is the human adenovirus multi-serotype Hexon chimeric antigen mentioned above, and the preparation method comprises the following steps: S1-Through the analysis of the dominant epitopes in the conservative region and the specific dominant epitopes in the hypervariable region of the hexon protein of human adenovirus types 3, 7, and 55, the 39-81aa and 103-258aa fragments of the type 3 Hexon protein, the 153-255aa fragment of the type 7 Hexon protein, and the 175-319aa fragment sequence of the type 55 Hexon protein were selected, and the nucleotide sequence that translates the amino acid was obtained as the target gene through codon optimization. The target gene was connected to the prokaryotic expression vector pGEX-4T-1 through gene synthesis, and the recombinant vector pGEX-4T-1-H3755 was successfully obtained.

[0021] Specifically: referring to human adenovirus type 3 (reference sequence Unprot: P36849), type 7 (reference sequence Unprot: P36851), and type 55 (reference sequence Unprot: A1YAF8), biological software was used to analyze the hydrophilicity, solubility, antigenicity, etc. of the protein. Generally, hydrophilicity and solubility are positively correlated with antigenicity; hydrophobicity and helical membrane region are negatively correlated with antigenicity. Analysis of hydrophilicity, antigenicity, and solubility showed that the strong antigenic regions mainly included conservative regions: 13-20aa, 39-81aa, 665-685aa, and 789-810aa; continuous epitopes in hypervariable regions: 103-257aa, 265-319aa, and 284-319aa; non-continuous epitopes in hypervariable regions: 404-434aa and 468-492aa; through the above comprehensive analysis, conservative region type 3 39-81aa was selected, and the sequence was shown in SEQ ID No.3; specific dominant epitope region: type 3 103-258aa, and the sequence was shown in SEQ ID No.4; type 7 153-255aa, and the sequence was shown in SEQ ID No.5; type 55 175-319aa, and the sequence was shown in SEQ ID No.6. The selected dominant epitope regions were connected by a connecting peptide, and the sequence was shown in SEQ ID NO.1. In order to increase the expression of the recombinant protein in E. coli, the codons preferred by E. coli were used to optimize the corresponding nucleotides in SEQ ID NO.1; the optimized nucleotide sequence is shown in SEQ ID No.2, and the optimized codon adaptation index CAI = 0.80 (the optimal codon adaptation index is 1). Figure 1As shown, the synthesized target gene was cloned into the multiple cloning sites BamH I and XhoI in the pGEX-4T-1 vector to construct the recombinant vector pGEX-4T-1-H3755.

[0022] S2-The recombinant expression vector pGEX-4T-1-H3755 obtained in step S1 is transformed into a host bacterium, and the recombinant engineered bacterium B / pGEX-4T-1-H3755 is obtained by screening.

[0023] The expression identification of recombinant engineering bacteria is as follows: the constructed recombinant vector pGEX-4T-1-H3755 is transformed into E. coli BL21 (DE3) competent cells, and spread on LB plates containing ampicillin resistance (100 μg / mL), inverted and cultured at 37°C overnight, pick the monoclonal strain on the plate to LB liquid culture medium containing ampicillin resistance (100 μg / mL), culture in a constant temperature shaker at 37°C for 5 hours, add isopropylthio-β-D-galactoside (IPTG) (final concentration of 0.5 mmol / L) to induce expression for 4 hours, collect bacterial precipitates and prepare protein electrophoresis samples. Figure 2 As shown, the SDS-PAGE electrophoresis results on the expression gel map showed that the recombinant protein was successfully expressed. The results showed that after induction, there was an obvious target band expression near 76.5kDa; the recombinant protein expression strain B / pGEX-4T-1-H3755 was successfully obtained.

[0024] S3-The recombinant engineered bacteria B / pGEX-4T-1-H3755 obtained in step S2 is cultured and induced to express, and the product is separated and purified to obtain the recombinant human adenovirus multi-serotype Hexon chimeric antigen.

[0025] The specific steps of inducing expression were as follows: 10 μl of recombinant plasmid expression bacteria were inoculated into 5 ml LB medium containing 100 ug / ml ampicillin (Amp) (purchased from Solebao), and cultured at 37°C, 200 rpm overnight (about 16 h). 200 μl of bacterial solution was added to 60 ml LB medium containing the same concentration of Amp, and cultured at 37°C, 200 rpm overnight. All bacterial solution was inoculated into 1 L LB medium containing the same concentration of Amp, and cultured at 28°C, 150 rpm for 2-2.5 h. After measuring the OD600 between 0.5 and 0.8, an inducer IPTG (purchased from AMRESCO) with a final concentration of 0.5 mM was added. After continuing to culture at 28°C, 150 rpm for 4.5 h, the culture was centrifuged at 6000 rpm for 5 min to collect the bacterial precipitate. The bacterial precipitate was washed with 50 ml 20 mM PBS (pH 7.4) Resuspend, centrifuge at 6000 rpm for 15 min, and collect the precipitate.

[0026] The specific steps for product separation and purification are as follows: high-pressure crushing - the bacterial precipitate is resuspended in 30 ml 20 mM PBS (pH 7.4) and crushed at low temperature and high pressure. The parameter settings are: pressure value 910-980 bar, 3 cycles, temperature setting 4°C, and the actual operating temperature shall not be higher than 13°C. After the crushing is completed, the crushed product is centrifuged at 9000 rpm for 30 minutes at low temperature, and the supernatant is collected. Protein purification - Take a GST tag affinity chromatography column: GST Bestarose 4FF (purchased from Boglon) for affinity chromatography, balance the column with 10 column volumes of ultrapure water; then balance the column with 10 column volumes of equilibration buffer (20mM PBS (pH 7.4)) and add the protein sample; after loading, wash away the unbound impurities with 10 column volumes of equilibration buffer (20mM PBS (pH 7.4)); then wash away the impurities with 10 column volumes of washing buffer (20mM Tris-HCl pH 8.0), and finally elute the target protein with elution buffer (20mM Tris-HCl -10 mM reduced glutathione pH8.0). Put the collected protein sample into a dialysis bag, put it into a beaker filled with dialysis solution (20 mM Tris-HCl pH 8.0), and dialyze overnight at 4°C. The purified protein samples were subjected to SDS-PAGE to detect the purification status, and steric hindrance high performance liquid chromatography (SEC-HPLC) was used to detect the presence of polymers and the purity analysis results, such as Figure 3 As shown, the target protein is around 76.5 kD in size, with a purity of ≥ 95% and a single form without aggregates.

[0027] The base sequence of the target gene obtained by codon optimization in step S1 is as described in SEQ ID NO.2. This sequence is a preferred nucleotide sequence after codon optimization for Escherichia coli expression, and a sequence with good expression. The host strain of the recombinant engineering bacteria B / pGEX-4T-1-H3755 in step S2 is Escherichia coli BL21 (DE3). The host bacteria is Escherichia coli, preferably Escherichia coli BL21 (DE3).

[0028] The preparation method obtains the recombinant expression of the dominant epitopes of Hexon of three serotypes of human adenovirus through molecular biological technology, thereby enhancing the positive detection rate of the target antigen in immunodiagnosis applications; obtains the nucleotide sequence of the H3755 antigen fragment through codon optimization, thereby improving the expression level of the recombinant protein in Escherichia coli; inserts the target gene into the BamH I / Xho I site of the pGEX-4T-1 vector multiple cloning site, so that the N-terminus of the expressed protein carries a GST tag for easy affinity purification, thereby improving the protein purity.

[0029] Embodiment 3: Application of human adenovirus multi-serotype Hexon chimeric antigen in a colloidal gold kit for detecting human adenovirus antibodies, wherein the human adenovirus multi-serotype Hexon chimeric antigen is the human adenovirus multi-serotype Hexon chimeric antigen described above, and the human adenovirus multi-serotype Hexon chimeric antigen prepared by the above-mentioned method for preparing a diagnostic antigen of the human adenovirus multi-serotype Hexon chimeric antigen; the human adenovirus multi-serotype Hexon chimeric antigen is used as the diagnostic antigen of the colloidal gold kit for detecting human adenovirus antibodies. The preparation of the colloidal gold kit for detecting human adenovirus antibodies comprises the following steps: S21—Colloidal gold labeling: Take 1mL of colloidal gold and put it in a small glass cup, stir and add an appropriate amount of 0.2MK2CO3 to adjust the pH to 7.6, stir for 1min; add 20μg of recombinant human adenovirus multi-serotype Hexon chimeric antigen (H3755), stir for 1 min; add 100μL1% PEG20000, stir for 1min; centrifuge at 5000g for 10 minutes, discard the supernatant, and resuspend the precipitate with 100ul colloidal gold diluent (component parameters: 20mM PB, 150mM NaCl, 0.1% PEG20000, 0.1% TritonX-100, 2% Sucrose, 0.01% NaN3); mix thoroughly and store at 4℃. Dilute the above gold-labeled complex 10 times with colloidal gold diluent and evenly apply it on the glass fiber, dry at 37℃ to make a gold-labeled pad; S22—Nitrocellulose membrane (NC membrane) coating: Coating diluent formula: 0.01M PB, pH 7.4, mass percentage concentration of 0.05% trehalose, the test line and quality control line are coated on the NC membrane from bottom to top, and then baked at 37℃ for 30min; S23—Assembly: Assemble the solid-phased NC membrane with the sample pad, S pad, gold label pad, PVC base plate, absorbent paper, and Mark sticker, and cut them into 3-4 mm test strips using a strip cutter.

[0030] Product sensitivity test: Use the prepared human adenovirus antibody test strips to test the human adenovirus positive quality control product. Figure 4 As shown, at the optimal labeling concentration, the color development is significantly higher than that of the comparison raw material, indicating that the raw material of the present invention has excellent sensitivity.

[0031] Product sample testing: The prepared human adenovirus antibody test strips were used to test 10 human adenovirus positive sera and 100 human adenovirus negative sera. The results are as follows Figure 5As shown in the table, the recombinant human adenovirus multi-serotype Hexon chimeric antigen (H3755) can be used as a labeling material in the test strip to detect positive samples of different serotypes, with high sensitivity and deep color; the control antigen missed the detection of positive samples of different serotypes, with low sensitivity and weak color. From the results of the negative sample test, H3755 has no false positives compared with the control antigen, and has excellent specificity.

[0032] The invention discloses a human adenovirus multi-serotype Hexon chimeric antigen machine preparation method and application, which overcomes the defects of the existing human adenovirus diagnosis antigen raw material subtype being single and the difficulty in preparing a diagnostic kit with mixed raw materials, etc. The method selects the Hexon dominant and specific antigen fragments of several major subtypes of domestically infected human adenovirus, combines the dominant epitope regions of the conserved regions of multiple subtypes, and prepares the human adenovirus antigen with strong antigenicity and high positive detection rate through chimeric expression, and uses the human adenovirus antigen as a diagnostic antigen for human adenovirus antibodies in a detection kit.

[0033] The above description shows the main features, basic principles, and advantages of the present invention. It is obvious to those skilled in the art that the present invention is not limited to the details of the above exemplary embodiments or embodiments, and the present invention can be implemented in other specific forms without departing from the spirit or basic features of the present invention. Therefore, the above embodiments or embodiments should be regarded as exemplary and non-restrictive. The scope of the present invention is defined by the attached claims rather than the above description, and it is intended that all changes falling within the meaning and scope of the equivalent elements of the claims are included in the present invention. Any figure mark in the claims should not be regarded as limiting the claims involved.

[0034] In addition, it should be understood that although the present specification is described according to implementation modes, not every implementation mode contains only one independent technical solution. This description of the specification is only for the sake of clarity. Those skilled in the art should regard the specification as a whole. The technical solutions in each embodiment may also be appropriately combined to form other implementation modes that can be understood by those skilled in the art.

Claims

1. A human adenovirus multi-serotype Hexon chimeric antigen, characterized in that: The antigen is composed of a series of dominant epitope regions of the conservative regions of type 3, type 7, and type 55 Hexon proteins and specific dominant epitope regions of the hypervariable regions. The dominant epitope of type 3 Hexon protein includes 39-81aa and 103-258aa fragments, and their amino acid sequences are respectively as described in SEQ ID NO.3 and SEQ ID NO.4; the dominant epitope of type 7 Hexon protein includes 153-255aa fragment, and its amino acid sequence is respectively as described in SEQ ID NO.5; the dominant epitope of type 55 Hexon protein includes 175-319aa fragment, and its amino acid sequence is respectively as described in SEQ ID NO.

5.

2. The human adenovirus multi-serotype Hexon chimeric antigen according to claim 1, characterized in that: The dominant epitope regions of the type 3, type 7 and type 55 Hexon proteins are connected by connecting peptides GGGS, (GGGS) 2 and AEAAAKA.

3. The human adenovirus multi-serotype Hexon chimeric antigen according to claim 2, characterized in that: The sequence of the amino acid sequence fragment of the antigen is as described in SEQ ID NO.

1.

4. A method for preparing a human adenovirus multi-serotype Hexon chimeric antigen, characterized in that: The human adenovirus multi-serotype Hexon chimeric antigen is the human adenovirus multi-serotype Hexon chimeric antigen according to any one of claims 1 to 3, and the preparation method comprises the following steps: S1-Through the analysis of the dominant epitopes in the conservative region and the specific dominant epitopes in the hypervariable region of the hexon protein of human adenovirus type 3, type 7, and type 55, the 39-81aa and 103-258aa fragments of type 3 Hexon protein, the 153-255aa fragment of type 7 Hexon protein, and the 175-319aa fragment sequence of type 55 Hexon protein were selected, and the nucleotide sequence that translates the amino acid was obtained as the target gene through codon optimization. The target gene was connected to the prokaryotic expression vector pGEX-4T-1 through gene synthesis, and the recombinant vector pGEX-4T-1-H3755 was successfully obtained; S2-transform the recombinant expression vector pGEX-4T-1-H3755 obtained in step S1 into the host bacteria, and screen to obtain the recombinant engineered bacteria B / pGEX-4T-1-H3755; S3-The recombinant engineered bacteria B / pGEX-4T-1-H3755 obtained in step S2 is cultured and induced to express, and the product is separated and purified to obtain the recombinant human adenovirus multi-serotype Hexon chimeric antigen.

5. The method for preparing a human adenovirus multi-serotype Hexon chimeric antigen according to claim 4, characterized in that: The base sequence of the target gene obtained by codon optimization in step S1 is as described in SEQ ID NO.

2.

6. The method for preparing a human adenovirus multi-serotype Hexon chimeric antigen according to claim 4, characterized in that: The host strain of the recombinant engineering bacteria B / pGEX-4T-1-H3755 in step S2 is Escherichia coli BL21 (DE3).

7. An application of a human adenovirus multi-serotype Hexon chimeric antigen, characterized in that: The invention is applied to a colloidal gold kit for detecting human adenovirus antibodies, wherein the human adenovirus multi-serotype Hexon chimeric antigen is the human adenovirus multi-serotype Hexon chimeric antigen as described in any one of claims 1 to 3, and the human adenovirus multi-serotype Hexon chimeric antigen obtained by the method for preparing a diagnostic antigen of the human adenovirus multi-serotype Hexon chimeric antigen as described in any one of claims 4 to 6; and the human adenovirus multi-serotype Hexon chimeric antigen is used as the diagnostic antigen of the colloidal gold kit for detecting human adenovirus antibodies.

8. The use of the human adenovirus multi-serotype Hexon chimeric antigen according to claim 7, characterized in that: The preparation method of the colloidal gold test kit for detecting human adenovirus antibodies comprises the following steps: S21—Colloidal gold labeling: Take 1mL of colloidal gold and put it in a small glass cup, stir and add an appropriate amount of 0.2MK2CO3 to adjust the pH to 7.6, stir for 1min; add 20μg of the human adenovirus multi-serotype Hexon chimeric antigen, stir for 1 min; add 100μL 1% PEG20000, stir for 1min; centrifuge at 5000g for 10 minutes, discard the supernatant, and resuspend the precipitate with 100ul colloidal gold diluent; mix thoroughly and store at 4℃. Dilute the above gold-labeled complex 10 times with colloidal gold diluent and evenly apply it on the glass fiber, dry at 37℃ to make a gold-labeled pad; S22—Nitrocellulose membrane coating: Coating diluent formula: 0.01M PB, pH 7.4, mass percentage concentration of 0.05% trehalose, the test line and quality control line are coated on the NC membrane from bottom to top, and then baked at 37℃ for 30min; S23—Assembly: Assemble the solid-phased NC membrane with the sample pad, S pad, gold label pad, PVC base plate, absorbent paper, and Mark sticker, and cut them into 3-4 mm test strips using a strip cutter.

9. The use of the human adenovirus multi-serotype Hexon chimeric antigen according to claim 7, characterized in that: The colloidal gold diluent component parameters in step S21 are 20 mM PB, 150 mM NaCl, 0.1% PEG20000, 0.1% TritonX-100, 2% Sucrose, and 0.01% NaN3.

Citation Information

Cited By

  • Nanometer antibody CTR96 targeting human type 4 adenovirus Hexon protein and application

    CN120463802A

  • Nanobody CTR96 targeting human adenovirus type 4 Hexon protein and its application

    CN120463802B